TABLE 5.
Sample no. | Genotypes by NS5b-based genotyping | Viral load (log IU/ml) | Genotype(s) identified by method based on the following region and procedurea:
|
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NS5b
|
5′ NC
|
||||||||||||||||||
IH | IH | IH | Tru | IH | IH | IH | Tru | IH | IH | IH | IH | Tru | Inno | Inno | Tru | Inno | |||
9 | 3a + 1b | 5.86 + 4.31 | 3a | 3a | 3a | 3a | 3a | 3a | 3ab | 3a | 3a | 3a | 3 | 0 | 3a | 3a | 3a | 3a | 3 |
11 | 1a + 1b | 4.93 + 4.31 | 0 | 1a | 1ab | 1a + 1b | 1a + 1b | 1b | 1b | 1a | 1a | 1a | 1a | 1 | 1ab | 1 | 1 | 1a | 1 |
14 | 1b + 3a | 5.68 + 4.01 | 1b | 1b | 1b | 1b | 1b | 1bb | 1b | 1b | 1b | 1b | 1b | 1b | 1b | 1b | 1b | 1 | 1b |
IH, in-house genotyping method; Tru, Trugene procedure; Inno, InnoLipa line probe assay procedure.
The presence of a double population was mentioned.